Alto Neuroscience (ANRO) Expected to Announce Quarterly Earnings on Thursday

Alto Neuroscience (NYSE:ANRO) is expected to be announcing its earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of ($0.65) per share for the quarter.

Alto Neuroscience Stock Up 2.1 %

ANRO stock opened at $3.46 on Thursday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 13.09 and a current ratio of 13.10. The business has a 50 day moving average price of $3.85 and a two-hundred day moving average price of $6.56. Alto Neuroscience has a twelve month low of $2.67 and a twelve month high of $18.35.

Analysts Set New Price Targets

Separately, Stifel Nicolaus cut their price objective on Alto Neuroscience from $32.00 to $10.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $16.75.

Alto Neuroscience Company Profile

Alto Neuroscience, Inc operates as a clinical-stage biopharmaceutical company in the United States. Its product pipeline comprising ALTO-100, which is in phase 2b clinical trial for the treatment of patients with major depressive disorder (MDD); and which is in phase 2a clinical trial for the treatment of post-traumatic stress disorder.